[Comparative human studies of a new anti-hypertensive drug (2,6-dichloro-benzylidene-aminoguanidine acetate) and methyldopa in hypertensive patients].
A between-patients trial between a new anti-hypertensive drug (Guanabenz) and methyldopa in subjects with essential hypertension showed the new preparation to be active and endowed with a satisfactory therapeutic index.